Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in&nbsp;patients with chronic heart failure

Original Research

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

Total article views		HTML views	PDF downloads	Totals
20,379	Dovepress*	18,159+	1,488	19,647
	PubMed Central*	2,220	834	3,054
	Totals	20,379	2,322	22,701
*Since 5 August 2015 +Since July 2016